Sharon Hassin‐Baer

Author

Sharon Hassin‐Baer

Also Known As

David Bates, Hassin-Baer, Sharon, John Hardy, S Hassin-Baer, S. Hassin-Baer, S. Hassin‐Baer, S. Hassin–Baer, Sharon Hassin-Baer, Sharon HassinBaer, Sharon Hassin‐Baer

211

Publications

7.9K

Citations

H-Index

152

Concepts

All Affiliations

Sheba Medical Center Tel Aviv University McGill University Montreal Neurological Institute and Hospital Columbia University Irving Medical Center

About

Sharon Hassin‐Baer is an author at Sheba Medical Center specializing in medicine, parkinson disease, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	49	2K
2	Social Sciences	15	18	664
3	Health Sciences	7	7	189
4	Public Health	4	4	198
5	Engineering	1	1	11

Sharon Hassin‐Baer

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Intravenous immunoglobulin treatment in multiple sclerosis Effect on relapses Anat Achiron, Uri Gabbay, R. Gilad, Neurology	1998	260
Novel <i>PINK1</i> mutations in early‐onset parkinsonism Shuichi Asakawa, Yasuhisa Yamamura, Hiroyuki Tomiyama, Annals of Neurology	2004	239
Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia Cornelis Blauwendraat, Xylena Reed, Lynne Krohn, Brain GeneticsGenetic EpidemiologyDisease Gene IdentificationGenome-wide Association StudiesGeriatric Neurology	2019	231
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome Catherine S. Storm, Demis A. Kia, Mona Mohammad Almramhi, Nature Communications	2021	204
Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets Demis A. Kia, David Zhang, Sebastian Guelfi, JAMA Neurology	2021	195
Neurological Outcome in Cerebrotendinous Xanthomatosis Treated With Chenodeoxycholic Acid Gilad Yahalom, Rakefet Tsabari, Noa Molshatzki, Clinical Neuropharmacology	2013	135
<i>SMPD1</i> mutations, activity, and α‐synuclein accumulation in Parkinson's disease Roy N. Alcalay, Victoria Mallett, Benoît Vanderperre, Movement Disorders	2019	110
Genetic, Structural, and Functional Evidence Link <i>TMEM175</i> to Synucleinopathies Lynne Krohn, Tuǧba N. Öztürk, Benoît Vanderperre, Annals of Neurology	2019	103
Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations Gilad Yahalom, Lior Greenbaum, Simon Israeli‐Korn, Parkinsonism & Related Disorders Genotype-phenotype CorrelationsNeurodegenerative DiseasesParkinson DiseaseGeneticsGenetic Epidemiology	2018	98
Higher Frequency of Certain Cancers in<i>LRRK2</i>G2019S Mutation Carriers With Parkinson Disease Ilir Agalliu, Marta San Luciano, Anat Mirelman, JAMA Neurology	2014	96

Page 1